PubMed HealthSearch

PubMed · 8649731

Autograft reconstructions.

Abstract

Autogenous bone and cartilage grafts provide the optimal material to be used in reconstruction of the skeleton. If there were an adequate supply of autogenous bone grafts of ideal size and shape, there would be no need for allograft or endoprosthetic replacements. Unfortunately, the major limitation to the use of autografts is their short supply. This is especially true when articular cartilage is needed. The other shortcoming of autogenouus grafts is the donor site morbidity, which, although modest, is of concern to the patient and, on rare occasions can lead to a significant complication. In the future, we may be able to have patients make their own autogenous bone and cartilage grafts, but for now we are limited to small corticocancellous grafts, strips of tibia or iliac crest, a rib, or the fibula. Clinically useful cartilage grafts can be obtained only from the proximal fibula or patella.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D Springfield. 1996. Autograft reconstructions.. https://pubmed.ncbi.nlm.nih.gov/8649731/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Is there a diagnostic role for bone scanning of patients with a high pretest probability for metastatic renal cell carcinoma?

BACKGROUND: The utility of performing whole-body bone scintigraphy (BS) as part of a routine staging workup for patients with renal cell carcinoma (RCC) is currently being debated. This study investigated the diagnostic performance of BS in 36 patients with a high pretest probability for bone metastases due to abnormal laboratory tests, pain, or confirmed nonosseous metastases. METHODS: Planar whole-body BS was performed in all patients 3 hours after the intravenous injection of 555 MBq (15 mCi) of technetium-99m-3,3-diphosphono-1,2-propane dicarboxylic acid tetrasodium salt). RESULTS: In 14 of 36 patients, bone metastases could be confirmed either due to computed tomography or magnetic resonance imaging (n=11) or open site directed biopsy (n=3), respectively. The sensitivity ranged from 10% to 60%, depending on the applied visual threshold. The extent of the metastatic involvement was underestimated in all cases. No diagnostic pattern of tracer accumulation, clinical features, or laboratory tests was identified as enhancing the sensitivity for the detection of bone metastases in this population. CONCLUSIONS: The authors concluded that, even among preselected patients, BS has no diagnostic role in RCC and should therefore be omitted from the clinical workup.

Bone Neoplasms